31/01/2012
ASX Release - Quarterly Cash Flow & Business Update

25/11/2011
ASX Release - AGM Results 2011

25/11/2011
2011 AGM Chairman's Presentation

02/11/2011
ASX Release - Conclusion of UK Clinical Study

Announcements

31 Jan 2012 - ASX Release - Quarterly Cash Flow & Business Update

25 Nov 2011 - ASX Release - AGM Results 2011

25 Nov 2011 - 2011 AGM Chairman's Presentation

02 Nov 2011 - ASX Release - Conclusion of UK Clinical Study

27 Oct 2011 - ASX Release - Quarterly Cash Flow

21 Oct 2011 - Notice of Annual General Meeting & Explanatory Statement

29 Sep 2011 - Annual Report Lodgement to Shareholders

27 Sep 2011 - AGM Date Announcement

26 Aug 2011 - FY11 Annual Report, Appendix 4E & Audit Report

17 Aug 2011 - ASX Release - Conclusion of agreement with R&D partner

03 Aug 2011 - Appendix 3B - New issue announcement, application of additional securities & agreement

01 Aug 2011 - Board & Executive changes; final directors' interest notices

27 Jul 2011 - Appendix 4C - Quartlery Report for Entities

04 Jul 2011 - ASX Release - Business Update; Outcome of Strategic Review

29 Jun 2011 - Appendix 3B - New Issue Announcement

10 Jun 2011 - Appendix 3B - Application for Quotation of Additional Securities & Agreement

29 Apr 2011 - ASX Announcement - Appendix 4C - Quarterly Cash Flow Report

14 Apr 2011 - Appendix 3B - New Issue Announcement

08 Apr 2011 - Appendix 3B - New Issue Announcement

08 Apr 2011 - Appendix 3Y - Change of Director's Interest Notice

01 Apr 2011 - ASX Release - Rights Issue closed & Proposed Issue of Options

23 Mar 2011 - ASX Announcement - Grant of Key U.S. Patent

21 Mar 2011 - ASX Announcement - Further Milestone Payment Received from Partner

11 Mar 2011 - ASX Announcement - Rights Issue Prospectus despatched

28 Feb 2011 - 2011 Non-renounceable Rights Issue - Prospectus & Appendix 3B

25 Feb 2011 - Appendix 4D - Half Year Report to 31 Dec 2010

23 Feb 2011 - ASX Announcement - Commercialisation & Development Update; Capital Raising Proposal

21 Feb 2011 - Market Release - Request for Trading Halt

31 Jan 2011 - ASX Announcement - Quarterly Cash Flow Report

05 Jan 2011 - ASX Release - R&D Alliance milestone payment

20 Dec 2010 - ASX Announcement - Securities Trading Policy

03 Dec 2010 - Appendix 3Y - Change of Director's Interest Notice

25 Nov 2010 - Appendix 3X Initial Director's Interest Notice

25 Nov 2010 - Appendix 3Z Final Director's Interest Notice

25 Nov 2010 - ASX Announcement - AGM Chairman's Address

25 Nov 2010 - ASX Announcement - Director Retirement/Board Appointments

25 Nov 2010 - ASX Announcement - AGM Results

25 Nov 2010 - ASX Announcement - AGM CEO Presentation

29 Oct 2010 - Appendix 4C - Quarterly Report

22 Oct 2010 - Notice of Annual General Meeting - 25 November 2010

08 Oct 2010 - Board Appointments; Director Retirement

29 Sep 2010 - ASX Announcement - 2010 Annual Report

28 Sep 2010 - AGM Date Announcement

16 Sep 2010 - Company Secretary Appointment

30 Aug 2010 - Appendix 4E - Preliminary Final Report Ending 30 June 2010

10 Aug 2010 - ASX Announcement - Expired Options

23 Jul 2010 - Appendix 4C - Quarterly Report to June 2010

11 Jun 2010 - Appendix 3B - Release of Shares from Escrow

28 May 2010 - ASX announcement: Release of shares from escrow

24 May 2010 - ASX announcement: R&D alliance with global top 10 partner

11 May 2010 - ASX announcement: Partnering with Healthscope on RTI-plex

30 Apr 2010 - Appendix 4C - Quarterly Report

19 Apr 2010 - ASX Announcement: PapType CE marked

05 Mar 2010 - ASX Announcement - Expiry of Unlisted Options

18 Feb 2010 - Appendix 4D - Half Year Report to December 2009

10 Feb 2010 - Appendix 3B - Issue of Shares and Options

22 Jan 2010 - Receipt of TGA approval for PapType

11 Dec 2009 - Appendix 3Y - Mel Bridges

01 Dec 2009 - Appointment of Chief Financial Officer

30 Nov 2009 - Appendix 3Y - Change in director's interests

19 Nov 2009 - Genera submits PapType for TGA review and ARTG listing

05 Nov 2009 - ASX Announcement - Placement to Sophisticated and Professional Investors

22 Oct 2009 - Appendix 4C - Quarterly Report

15 Oct 2009 - Genera receives TGA licence to manufacture

17 Sep 2009 - 2009 Annual Report

04 Sep 2009 - ASX release: Genera announces major clinical study results

26 Aug 2009 - Appendix 4E and Preliminary Final Report

19 Aug 2009 - Appendix 3Y correction

20 Jul 2009 - ASX release: Update on TGA audit process

15 Jul 2009 - Appendix 3B: Issuance of New Shares

10 Jul 2009 - ASX announcement - EGM results

15 Jun 2009 - Company Update

09 Jun 2009 - Announcement of EGM

21 May 2009 - Company Announcement - Appendix 3Y and Form 603

18 May 2009 - Genera announces A$2.99m Placement

30 Apr 2009 - Appendix 4C and Company Update

08 Apr 2009 - ASX release: PapType performs well compared to cytology

02 Apr 2009 - ASX release - lapsed options

02 Apr 2009 - ASX Announcement - ESOP Allocations

25 Feb 2009 - Appendix 4D - Preliminary Final Report

09 Feb 2009 - ASX Announcement - Options Pricing and Change to Registered Office

22 Jan 2009 - Appendix 4C - December 2008 Quarter

08 Jan 2009 - ASX release: Grant of patent

16 Dec 2008 - Appendix 3Z: Final director's interest notice: Matt Harris

15 Dec 2008 - Appendix 3F - Director's initial interests

12 Dec 2008 - ASX Release - Mel Bridges To Join Board of Genera Biosystems

12 Dec 2008 - Appendix 3B - Escrowed Shares and Lapsed Options

09 Dec 2008 - Appendix 3Y. Change in Director's Interests (FC)

05 Dec 2008 - Appendix 3Y. Change in Director's Interests (DS)

04 Dec 2008 - ASX release: ESOP amendment

04 Dec 2008 - Appendix 3Y. Change in Director's Interests (DS)

01 Dec 2008 - Appendix 3Y: Change in Director's Interests (KP)

28 Nov 2008 - ASX release: Release of stock from escrow

26 Nov 2008 - ASX release: AGM: Chairman's speech

21 Nov 2008 - Appendix 3B - Issue of options (AB)

17 Nov 2008 - Appendix 3B - Newly Listed Shares

11 Nov 2008 - Appendix 3B - Newly Listed Shares

31 Oct 2008 - ASX release: Release from escrow

31 Oct 2008 - Appendix 4C - Quarterly Cashflow

24 Oct 2008 - ASX release: AGM 26 November 2008